Sue Ellen Cox, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Allergan
    Topic: 
    Principal Investigator, Consultant, Advisory Boards
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Evolus
    Topic: 
    Principal Investigator, Consultant, Advisory Boards
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Galderma
    Topic: 
    Principal Investigator, Consultant, Advisory Boards
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Merz
    Topic: 
    Consultant, Advisory Board
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Revance
    Topic: 
    Principal Investigator, Consultant, Advisory Boards
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Croma-Pharma
    Topic: 
    Principal Investigator, Consultant
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Cearna Aesthetics
    Topic: 
    Consultant
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Zeltiq
    Topic: 
    Principal Investigator, Consultant, Advisory Boards
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Pulse BioSciences
    Topic: 
    Consultant
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Solta Medical
    Topic: 
    Consultant, Advisory Board
    Date added: 
    04/26/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/16/2022

Pages

Return to "Dermatology Rising, Beyond the Pandemic" CME Conference (RP2206A)